Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikolaus Schultz

Showing results (191-200 of 310) with videos related to

Pageof 31
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2025
Clinical Implications of The Cancer Genome Atlas Molecular Classification System in Esophagogastric CancerHenry S Walch, Raktim Borpatragohain, Justin Jee, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2009
The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancersSelvaraju Veeriah, Cameron Brennan, Shasha Meng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 2018
Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune TherapiesJames J Harding, Subhiksha Nandakumar, Joshua Armenia, et al.
European Urology|October 7, 2018
Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant ChemotherapyEugene J Pietzak, Emily C Zabor, Aditya Bagrodia, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
Sharing Data from the Human Tumor Atlas Network through Standards, Infrastructure, and Community EngagementIno de Bruijn, Milen Nikolov, Clarisse Lau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 29, 2017
Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct PathogenesisMatthew T Chang, Alexander Penson, Neil B Desai, et al.
JCO Precision Oncology|December 14, 2019
Harmonization of Tumor Mutational Burden Quantification and Association With Response to Immune Checkpoint Blockade in Non-Small-Cell Lung CancerNatalie I Vokes, David Liu, Biagio Ricciuti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 13, 2022
Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for InterventionNicolas A Giraldo, Esther Drill, Baby A Satravada, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Paired primary-metastasis patient-derived organoids and mouse models identify phenotypic evolution and druggable dependencies of peritoneal metastasis from appendiceal cancerAhmed Mahmoud, Philip H Choi, Christine Sukhwa, et al.
JAMA Oncology|November 15, 2019
Development of Genome-Derived Tumor Type Prediction to Inform Clinical Cancer CareAlexander Penson, Niedzica Camacho, Youyun Zheng, et al.
Pageof 31

Showing results (191-200 of 310) with videos related to

Sort By:
Pageof 31
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2025
Clinical Implications of The Cancer Genome Atlas Molecular Classification System in Esophagogastric CancerHenry S Walch, Raktim Borpatragohain, Justin Jee, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2009
The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancersSelvaraju Veeriah, Cameron Brennan, Shasha Meng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 2018
Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune TherapiesJames J Harding, Subhiksha Nandakumar, Joshua Armenia, et al.
European Urology|October 7, 2018
Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant ChemotherapyEugene J Pietzak, Emily C Zabor, Aditya Bagrodia, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
Sharing Data from the Human Tumor Atlas Network through Standards, Infrastructure, and Community EngagementIno de Bruijn, Milen Nikolov, Clarisse Lau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 29, 2017
Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct PathogenesisMatthew T Chang, Alexander Penson, Neil B Desai, et al.
JCO Precision Oncology|December 14, 2019
Harmonization of Tumor Mutational Burden Quantification and Association With Response to Immune Checkpoint Blockade in Non-Small-Cell Lung CancerNatalie I Vokes, David Liu, Biagio Ricciuti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 13, 2022
Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for InterventionNicolas A Giraldo, Esther Drill, Baby A Satravada, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Paired primary-metastasis patient-derived organoids and mouse models identify phenotypic evolution and druggable dependencies of peritoneal metastasis from appendiceal cancerAhmed Mahmoud, Philip H Choi, Christine Sukhwa, et al.
JAMA Oncology|November 15, 2019
Development of Genome-Derived Tumor Type Prediction to Inform Clinical Cancer CareAlexander Penson, Niedzica Camacho, Youyun Zheng, et al.
Pageof 31